ad image

HIV-1

1 / 1
U.S. Food & Drug Administration
HIV-1

FDA Authorizes Marketing of First Next-Generation Sequencing Test for Detecting HIV-1 Drug Resistance Mutations

U.S. Food & Drug Administration

PR-M11-19-NI-008Nov 08, 2019
The US Food & Drug Administration
HIV Prevention

FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic

The US Food & Drug Administration

PR-M10-19-NI-008Oct 07, 2019
Janssen Pharmaceutical Companies
Study Results

Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the Treatment of HIV-1

Janssen Pharmaceutical Companies

PR-M09-18-NI-045Sep 17, 2018
Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval
FDA Approval

Merck’s HIV-1 Drugs Delstrigo and Pifeltro Get FDA Approval

Cynthia A. Challener, Ph.D.

Pharma's Almanac

PAO-M09-18-NI-003Sep 06, 2018
Janssen Pharmaceutical Companies
Commission Approval

Janssen Announces European Commission Approval of JULUCA®▼ (dolutegravir/rilpivirine), the First Two-Drug Regimen, Once-Daily, Single-Pill for the Treatment of HIV-1

Janssen Pharmaceutical Companies

PR-M05-18-NI-088May 23, 2018
New Single-Pill HIV Treatment Approved in Europe
Treatment

New Single-Pill HIV Treatment Approved in Europe

Guy Tiene

Nice Insight

PAO-M05-18-NI-015May 22, 2018
Gilead Sciences
FDA Approval

U.S. Food and Drug Administration Approves Expanded Indication for Truvada®

Gilead Sciences

PR-M05-18-NI-073May 18, 2018
1 / 1